Cryoablation or tumor freezing is emerging as a minimally invasive alternative to breast conserving surgery for the management of breast cancer.  In addition to reducing the morbidity of breast cancer surgery, this office-based, percutaneous procedure reduces the psychosocial and cosmetic impact of breast cancer therapy by eliminating the need for surgical resection.  In the presentation, I will discuss the technical considerations of cryoablation as well as the evolving indications for early and advanced stage breast cancer in the context of patient centered care.

Dennis R. Holmes, M.D. is an internationally renowned breast cancer, surgeon, surgeon educator, and cancer researcher specializing in the management of breast cancer.  Dr. Holmes is medical director of the Sam and Grace Carvajal Comprehensive Breast Center at Adventist Health Glendale in Los Angeles, CA. He completed his medical education at Tulane University School of Medicine, surgical residency in general surgery at the University of San Francisco, and a fellowship in breast surgery at the University of Southern California. He is a board-certified Fellow of the American College of Surgeons and recently served as Program Chair of the 20th Annual National Meeting of the American Society of Breast Surgeons and is the 2023 Health Policy Scholar for the American College of Surgeons. He has also served as department head of several academic breast cancer programs and program director of two breast surgery fellowship programs. His has also played a pivotal role in several breast cancer treatment innovations, including intraoperative radiotherapy, oncoplastic surgery, and cryoablation